DOJ Deal Ends Monopoly for Texas Health System
United Regional Health Care System has agreed to a demand from federal prosecutors that it no longer block health plans from contracting with other hospitals in the Wichita Falls, TX area, the Department of Justice has announced.
Federal prosecutors said URHCS illegally used contracts to maintain its monopoly for hospital services in violation of the Sherman Act, which meant that consumers paid more for healthcare. This is the first case brought by DOJ since 1999 that challenges a monopoly with in traditional anticompetitive unilateral conduct.
"Unfettered competition among hospitals is vital to ensuring that patients receive high-quality, low-cost healthcare," said Christine Varney, assistant Attorney General in charge of the Department of Justice's Antitrust Division. "Today's settlement prevents a dominant hospital from using its market power to harm consumers by undermining its competitors' ability to compete in the marketplace."
Phyllis Cowling, president/CEO of URHCS, said the private, nonprofit health system "was pleased with the resolution" of the investigation.
"While we disagree with the Department's interpretation of the facts and would have welcomed the opportunity to address this matter in a court of law, we believe it is in the best interest of United Regional and our patients to instead move forward with our total attention and resources focused on our passion of providing excellence in healthcare for the communities we serve," Cowling said in a statement posted on the URHCS Web site.
- CMS Sets 2014 Pay Rates for Hospital Outpatient and Physician Services
- FDA hopes hospitals will switch to newly regulated pharmacies
- The 5 Biggest Healthcare Finance Trouble Spots
- Not-for-Profit Hospitals Find Opportunity Amid Uncertainty
- Nonprofit Hospital Outlook 'Negative' in 2014
- The Most Polarizing Topics in Healthcare IT
- Are ACOs Really Different from HMOs?
- How CPOE Will Make Healthcare Smarter
- Why You Should Involve Patients in Nursing Handoffs
- Rise of the Chief Strategy Officer